4.7 Article

Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors

Journal

JOURNAL OF INTERNAL MEDICINE
Volume 290, Issue 3, Pages 621-631

Publisher

WILEY
DOI: 10.1111/joim.13262

Keywords

COVID-19; sequelae; neurocognitive; psychiatric morbidity; quality of life

Funding

  1. Rio Hortega grant - Instituto de Salud Carlos III (ISCIII) [CM19/00182]
  2. Health Research Institute La Fe [2019-053-1]
  3. NHMRC Senior Principal Research Fellowship [1059660, 1156072]

Ask authors/readers for more resources

The study found that COVID-19 survivors shortly after hospital discharge showed a high prevalence of neurocognitive impairment, psychiatric morbidity, and poor quality of life. Female gender was more likely to be associated with psychiatric morbidity, while delirium and psychiatric morbidity were related to neurocognitive impairment.
Background The general medical impacts of coronavirus (COVID-19) are increasingly appreciated. However, its impact on neurocognitive, psychiatric health and quality of life (QoL) in survivors after the acute phase is poorly understood. We aimed to evaluate neurocognitive function, psychiatric symptoms and QoL in COVID-19 survivors shortly after hospital discharge. Methods This was a cross-sectional analysis of a prospective study of hospitalized COVID-19 survivors followed up for 2 months after discharge. A battery of standardized instruments evaluating neurocognitive function, psychiatric morbidity and QoL (mental and physical components) was administered by telephone. Results Of the 229 screened patients, 179 were included in the final analysis. Amongst survivors, the prevalence of moderately impaired immediate verbal memory and learning was 38%, delayed verbal memory (11.8%), verbal fluency (34.6%) and working memory (executive function) (6.1%), respectively. Moreover, 58.7% of patients had neurocognitive impairment in at least one function. Rates of positive screening for anxiety, depression and post-traumatic stress disorder were 29.6%, 26.8% and 25.1%, respectively. In addition, 39.1% of the patients had psychiatric morbidity. Low QoL for physical and mental components was detected in 44.1% and 39.1% of patients respectively. Delirium and psychiatric morbidity were associated with neurocognitive impairment, and female gender was related with psychiatric morbidity. Conclusion Hospitalized COVID-19 survivors showed a considerable prevalence of neurocognitive impairment, psychiatric morbidity and poor QoL in the short term. It is uncertain if these impacts persist over the long term.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available